[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (vol 47, pg 849, 2020)

被引：2
|
作者：
van Helden, E. J. [1 ]
Elias, S. G. [2 ]
Gerritse, S. L. [1 ]
van Es, S. C. [3 ]
Boon, E. [4 ]
Huisman, M. C. [5 ]
van Grieken, N. C. T. [6 ]
Dekker, H. [1 ]
van Dongen, G. A. M. S. [5 ]
Vugts, D. J. [5 ]
Boellaard, R.
van Herpen, C. M. L. [4 ]
de Vries, E. G. E. [3 ]
Oyen, W. J. G. [7 ,8 ,9 ]
Brouwers, A. H. [10 ]
Verheul, H. M. W. [1 ]
Hoekstra, O. S.
Menke-van der Houven van Oordt, C. W. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构：
[1] Amsterdam UMC, Locat VU Med Ctr, Canc Ctr Amsterdam, Med Oncol, Amsterdam, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Med Oncol, Nijmegen, Netherlands
[5] Amsterdam UMC, Locat VU Med Ctr, Canc Ctr Amsterdam, Radiol & Nucl Med, Amsterdam, Netherlands
[6] Amsterdam UMC, Locat VU Med Ctr, Canc Ctr Amsterdam, Pathol, Amsterdam, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Radiol & Nucl Med, Nijmegen, Netherlands
[8] Inst Canc Res, London, England
[9] Royal Marsden Hosp, London, England
[10] Univ Groningen, Univ Med Ctr Groningen, Nucl Med & Mol Imaging, Groningen, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 10期
关键词：
D O I：
10.1007/s00259-020-04908-6
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Missing Electronic Supplementary Materials.
引用
收藏
页码：2481 / 2481
页数：1
相关论文
共 50 条
  • [1] [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
    van Helden, E. J.
    Elias, S. G.
    Gerritse, S. L.
    van Es, S. C.
    Boon, E.
    Huisman, M. C.
    van Grieken, N. C. T.
    Dekker, H.
    van Dongen, G. A. M. S.
    Vugts, D. J.
    Boellaard, R.
    van Herpen, C. M. L.
    de Vries, E. G. E.
    Oyen, W. J. G.
    Brouwers, A. H.
    Verheul, H. M. W.
    Hoekstra, O. S.
    van Oordt, C. W. Menke-van der Houven
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 849 - 859
  • [2] [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
    E. J. van Helden
    S. G. Elias
    S. L. Gerritse
    S. C. van Es
    E. Boon
    M. C. Huisman
    N. C. T. van Grieken
    H. Dekker
    G. A. M. S. van Dongen
    D. J. Vugts
    R. Boellaard
    C. M. L. van Herpen
    E. G. E. de Vries
    W. J. G. Oyen
    A. H. Brouwers
    H. M. W. Verheul
    O. S. Hoekstra
    C. W. Menke-van der Houven van Oordt
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 849 - 859
  • [3] Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
    E. J. van Helden
    S. G. Elias
    S. L. Gerritse
    S. C. van Es
    E. Boon
    M. C. Huisman
    N. C. T. van Grieken
    H. Dekker
    G. A. M. S. van Dongen
    D. J. Vugts
    R. Boellaard
    C. M. L. van Herpen
    E. G. E. de Vries
    W. J. G. Oyen
    A. H. Brouwers
    H. M. W. Verheul
    O. S. Hoekstra
    C. W. Menke-van der Houven van Oordt
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2481 - 2481
  • [4] 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
    van Oordt, Catharina Willemien Menke-van der Houven
    Gootjes, Elske C.
    Huisman, Marc C.
    Vugts, Danielle J.
    Roth, Chantal
    Luik, Anne Marije
    Mulder, Emma R.
    Schuit, Robert C.
    Boellaard, Ronald
    Hoekstra, Otto S.
    van Dongen, Guus A. M. S.
    Verheul, Henk M. W.
    [J]. ONCOTARGET, 2015, 6 (30) : 30384 - 30393
  • [5] ImmunoPET imaging with 89Zr-cetuximab in patients with advanced colorectal cancer
    Menke, Catharina Wilhelmina
    Gootjes, Elske C.
    Huisman, Marc C.
    van Grieken, Nicole C. T.
    Vugts, Danielle J.
    Roth, Chantal
    Mulder, Emma R.
    Schuit, Robert C.
    Boellaard, Ronald
    Hoekstra, Otto S.
    van Dongen, G. A. M. S.
    Verheul, Henk M. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] 89Zr-cetuximab imaging in advanced colorectal cancer patients: A feasibility study
    van Oordt, C. W. Menke-van der Houven
    Huisman, M.
    Roth, C.
    Vugts, D. J.
    Schuit, R. C.
    Clement, A.
    Boellaard, R.
    Hoekstra, O. S.
    Van Dongen, G. A. M. S.
    Verheul, H. M. W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S245 - S246
  • [7] Pharmacokinetics of cetuximab and tumor uptake of 89Zr-cetuximab as potential predictive biomarkers for benefit of cetuximab in patients with advanced colorectal cancer.
    Van Helden, Erik Jacobus
    Menke, Catharina Wilhelmina
    Boon, Eline
    van Es, Suzanne
    Huisman, Marc C.
    van Dongen, G. a. M. S.
    Vugts, Danielle J.
    De Groot, Derk Jan
    Herpen, Carla M. L. -Van
    De Vries, Elisabeth
    Hoekstra, Otto S.
    Verheul, Henk M. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Imaging tumor biology with 89Zr-cetuximab, 15O-H2O and 18F-FDG PET/CT in patients with advanced colorectal cancer treated with cetuximab monotherapy
    van Helden, E. J.
    Hoekstra, O. S.
    Huisman, M. C.
    Boon, E.
    van Es, S. C.
    van Dongen, G. A. M. S.
    Vugts, D. J.
    de Groot, D. J.
    Boellaard, R.
    van Herpen, C. M. L.
    de Vries, E. G. E.
    Verheul, H. M. W.
    van Oordt, C. W. Menke-van der Houven
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S148 - S148
  • [9] Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
    Fountzilas, Christos
    Bajor, David L.
    Mukherjee, Sarbajit
    Saltzman, Joel
    Witkiewicz, Agnieszka K.
    Maguire, Orla
    Minderman, Hans
    Nambiar, Ram
    Rosenheck, Hanna R.
    Knudsen, Erik S.
    Muhitch, Jason B.
    Abrams, Scott, I
    Wang, Chong
    Hutson, Alan D.
    Attwood, Kristopher
    Hicks, Karen A.
    Jurcevic, Jennifer A.
    Kalinski, Pawel
    Iyer, Renuka
    Boland, Patrick M.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (24) : 6726 - 6736
  • [10] CIRCULATING TUMOR CELLS (CTCS) AS PROGNOSTIC BIOMARKER IN PATIENTS WITH ADVANCED CHEMOREFRACTORY, RAS WILD-TYPE COLORECTAL CANCER (CRC) TREATED WITH CETUXIMAB OR PANITUMUMAB
    Musella, V.
    Pietrantonio, F.
    Di Buduo, E.
    Bossi, I.
    Iacovelli, R.
    Maggi, C.
    Martinetti, A.
    Sottotetti, E.
    Di Bartolomeo, M.
    de Braud, F.
    Cappelletti, V.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
12345